{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:32:33Z","timestamp":1790195553269,"version":"4.1.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In children born small for gestational age (SGA) with persistent short stature, 2 years of gonadotropin-releasing hormone analogue (GnRHa), in addition to long-term growth hormone (GH) treatment, can improve adult height. We assessed safety on metabolic and bone health of GnRHa\/GH treatment during 5 years after cessation of GH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 363 young adults born SGA, previously treated with combined GnRHa\/GH or GH-only, were followed for 5 years after attainment of adult height at GH cessation and 2 and 5 years thereafter. Data at 5 years after GH cessation, at age 21 years, were also compared with 145 age-matched adults born appropriate for gestational age (AGA). Frequently sampled intravenous glucose tolerance (FSIGT) tests were used to assess insulin sensitivity, acute insulin response, and \u03b2-cell function. Body composition and bone mineral density (BMD) was determined by dual-energy x-ray absorptiometry (DXA) scans.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>In the GnRHa\/GH and GH-only groups, fat mass increased during the 5 years after GH cessation, but the changes in FSIGT results, body composition, blood pressure, serum lipid levels, and BMD were similar in both groups. At age 21 years, the GnRHa\/GH group had similar fat mass, FSIGT results, blood pressure, serum lipid levels and BMD-total body as the GH-only group and the AGA control group, a higher BMD-lumbar spine and lower lean body mass than the AGA control group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>This study during 5 years after GH cessation shows that addition of 2 years of GnRHa treatment to long-term GH treatment of children short in stature born SGA has no unfavorable effects on metabolic and bone health in early adulthood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical trial registration<\/jats:title>\n                  <jats:p>ISRCTN96883876, ISRCTN65230311 and ISRCTN18062389.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa287","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T14:08:10Z","timestamp":1590070090000},"page":"e2796-e2806","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-1090","authenticated-orcid":false,"given":"Wesley J","family":"Goedegebuure","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Subdivision Endocrinology, Erasmus University Medical Centre, Rotterdam, The Netherlands"},{"name":"Dutch Growth Research Foundation, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouk","family":"van der Steen","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerthe F","family":"Kerkhof","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Subdivision Endocrinology, Erasmus University Medical Centre, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C S","family":"Hokken-Koelega","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Subdivision Endocrinology, Erasmus University Medical Centre, Rotterdam, The Netherlands"},{"name":"Dutch Growth Research Foundation, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"issue":"9","key":"2021122109124565000_CIT0001","first-page":"3064","article-title":"Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial","volume":"84","author":"Sas","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122109124565000_CIT0002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","article-title":"Final height in short children born small for gestational age treated with growth hormone","volume":"57","author":"Dahlgren","year":"2005","journal-title":"Pediatr Res."},{"issue":"8","key":"2021122109124565000_CIT0003","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2002-021172","article-title":"Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial","volume":"88","author":"Van Pareren","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122109124565000_CIT0004","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122109124565000_CIT0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2021122109124565000_CIT0006","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1210\/jc.2010-0731","article-title":"Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression","volume":"95","author":"S\u00f8rensen","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122109124565000_CIT0007","first-page":"27","article-title":"The effect of gonadotropin-releasing hormone analog treatment (leuprolide) on body fat distribution in idiopathic central precocious puberty","volume":"53","author":"Ta\u015fcilar","year":"2011","journal-title":"Turk J Pediatr."},{"issue":"3","key":"2021122109124565000_CIT0008","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000456546","article-title":"Metabolic outcomes, bone health, and risk of polycystic ovary syndrome in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogues","volume":"87","author":"Faienza","year":"2017","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2021122109124565000_CIT0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2009-0793","article-title":"The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study","volume":"95","author":"Magiakou","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122109124565000_CIT0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122109124565000_CIT0011","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1515\/JPEM.2006.19.11.1327","article-title":"Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues","volume":"19","author":"Aguiar","year":"2006","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"2","key":"2021122109124565000_CIT0012","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jcem.87.2.8202","article-title":"Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy","volume":"87","author":"van der Sluis","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122109124565000_CIT0013","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2265.2012.04418.x","article-title":"The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty","volume":"77","author":"Park","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122109124565000_CIT0014","first-page":"370","article-title":"Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty","volume":"83","author":"Boot","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122109124565000_CIT0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF01953983","article-title":"Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty","volume":"152","author":"Saggese","year":"1993","journal-title":"Eur J Pediatr."},{"issue":"4","key":"2021122109124565000_CIT0016","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1530\/eje.0.1330412","article-title":"Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment","volume":"133","author":"Antoniazzi","year":"1995","journal-title":"Eur J Endocrinol."},{"issue":"10","key":"2021122109124565000_CIT0017","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1210\/jc.2015-2619","article-title":"Metabolic health in short children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analog: results of a randomized, dose-response trial","volume":"100","author":"van der Steen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122109124565000_CIT0018","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2015-3435","article-title":"Insulin sensitivity and \u03b2-cell function in SGA children treated with GH and GnRHa: results of a long-term trial","volume":"101","author":"van der Steen","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122109124565000_CIT0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/jc.2012-2492","article-title":"Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment","volume":"98","author":"Lem","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122109124565000_CIT0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1203\/00006450-200003000-00006","article-title":"Continuing positive secular growth change in The Netherlands 1955\u20131997","volume":"47","author":"Fredriks","year":"2000","journal-title":"Pediatr Res."},{"key":"2021122109124565000_CIT0021","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpeds.2012.03.048","article-title":"Does preterm birth influence cardiovascular risk in early adulthood?","volume":"161","author":"Kerkhof","year":"2012","journal-title":"J Pediatr."},{"issue":"21","key":"2021122109124565000_CIT0022","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2009.761","article-title":"Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood","volume":"301","author":"Leunissen","year":"2009","journal-title":"JAMA."},{"issue":"3","key":"2021122109124565000_CIT0023","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02556113","article-title":"Precision and stability of dual-energy x-ray absorptiometry measurements","volume":"49","author":"Johnson","year":"1991","journal-title":"Calcif Tissue Int."},{"issue":"12","key":"2021122109124565000_CIT0024","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/oby.2004.241","article-title":"The intra- and inter-instrument reliability of DXA based on ex vivo soft tissue measurements","volume":"12","author":"Guo","year":"2004","journal-title":"Obes Res."},{"issue":"2","key":"2021122109124565000_CIT0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S8756-3282(95)00162-X","article-title":"Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology","volume":"17","author":"Kr\u00f6ger","year":"1995","journal-title":"Bone."},{"issue":"2","key":"2021122109124565000_CIT0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ajcn\/66.2.232","article-title":"Determinants of body composition measured by dual-energy x-ray absorptiometry in Dutch children and adolescents","volume":"66","author":"Boot","year":"1997","journal-title":"Am J Clin Nutr."},{"issue":"4","key":"2021122109124565000_CIT0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.87.4.341","article-title":"Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults","volume":"87","author":"van der Sluis","year":"2002","journal-title":"Arch Dis Child."},{"issue":"6","key":"2021122109124565000_CIT0028","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3476(05)80382-8","article-title":"Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States","volume":"123","author":"Rosner","year":"1993","journal-title":"J Pediatr."},{"issue":"4","key":"2021122109124565000_CIT0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000197862","article-title":"Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height","volume":"89","author":"Chiocca","year":"2009","journal-title":"Neuroendocrinology."},{"issue":"8","key":"2021122109124565000_CIT0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ijo.2012.177","article-title":"Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis","volume":"37","author":"Prentice","year":"2013","journal-title":"Int J Obes (Lond)."},{"key":"2021122109124565000_CIT0031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fped.2019.00074","article-title":"Transient arterial hypertension induced by gonadotropin-releasing hormone agonist treatment for central precocious puberty","volume":"7","author":"Sifaki","year":"2019","journal-title":"Front Pediatr."},{"issue":"3","key":"2021122109124565000_CIT0032","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/jpem-2018-0210","article-title":"Does the risk of arterial hypertension increase in the course of triptorelin treatment?","volume":"33","author":"Palma","year":"2020","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"2","key":"2021122109124565000_CIT0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/jpem-2018-0290","article-title":"One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty","volume":"32","author":"Arcari","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"12","key":"2021122109124565000_CIT0034","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2213-8587(17)30311-X","article-title":"Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study","volume":"5","author":"van der Steen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2021122109124565000_CIT0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(16)30422-3","article-title":"Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study","volume":"5","author":"van der Steen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021122109124565000_CIT0036","doi-asserted-by":"crossref","first-page":"591","DOI":"10.6061\/clinics\/2012(06)08","article-title":"Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist","volume":"67","author":"Alessandri","year":"2012","journal-title":"Clinics (Sao Paulo)."},{"issue":"12","key":"2021122109124565000_CIT0037","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa287\/33245574\/dgaa287.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/8\/e2796\/41830115\/jcem_105_8_e2796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/8\/e2796\/41830115\/jcem_105_8_e2796.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:14:02Z","timestamp":1640078042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/8\/e2796\/5841626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,5,21]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa287","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,5,21]]}}}